3α-Androstandiol
Изглед
![]() | |
Nazivi | |
---|---|
IUPAC naziv
(3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimetil-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradekahidro-1H-ciklopenta[a]fenantren-3,17-diol
| |
Drugi nazivi
Hombreol
| |
Identifikacija | |
3D model (Jmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.015.862 |
| |
Svojstva | |
C19H32O2 | |
Molarna masa | 292,46 g/mol |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
3α-Androstandiol (5α-androstan-3α,17β-diol) je androstandiol[3] izveden iz DHT u reakciji koju katalizuje enzim 3-α-HSD.
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Frye CA (2007). „Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol”. Pharmacol. Biochem. Behav. 86 (2): 354—67. PMC 1857333
. PMID 17112575. doi:10.1016/j.pbb.2006.10.003.